120 related articles for article (PubMed ID: 2842389)
1. Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.
Tantucci C; Santeusanio F; Beschi M; Castellano M; Sorbini C; Grassi V
J Endocrinol Invest; 1988 Apr; 11(4):279-87. PubMed ID: 2842389
[TBL] [Abstract][Full Text] [Related]
2. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
[TBL] [Abstract][Full Text] [Related]
4. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of prenalterol in healthy volunteers.
Klein G; Wirtzfeld A; Schmidt G; Zilker T
Acta Med Scand Suppl; 1982; 659():137-46. PubMed ID: 6127884
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
Vincent HH; Boomsma F; Man in't Veld AJ; Derkx FH; Wenting GJ; Schalekamp MA
J Cardiovasc Pharmacol; 1984; 6(1):107-14. PubMed ID: 6199591
[TBL] [Abstract][Full Text] [Related]
7. Some metabolic and hormonal effects of salbutamol in man.
Massara F; Fassio V; Camanni F; Martina V; Molinatti G
Acta Diabetol Lat; 1976; 13(3-4):146-53. PubMed ID: 1020612
[TBL] [Abstract][Full Text] [Related]
8. Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.
Berend N; Marlin GE
Br J Clin Pharmacol; 1978 Mar; 5(3):207-11. PubMed ID: 207295
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and hormonal responses to salbutamol in asthma. Evidence of beta-adrenergic overactivity?
Kallenbach JM; Panz VR; Jankelow D; Joffe BI; Seftel HC
Respiration; 1990; 57(1):21-7. PubMed ID: 2163093
[TBL] [Abstract][Full Text] [Related]
10. Practolol inhibition of some salbutamol-induced metabolic and hormonal responses.
Massara F; Martina V; Fassio V; Sapelli S; Molinatti G
Acta Diabetol Lat; 1977; 14(5-6):257-62. PubMed ID: 207065
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
Wheeldon NM; McDevitt DG; McFarlane LC; Lipworth BJ
Clin Sci (Lond); 1994 Mar; 86(3):331-7. PubMed ID: 7908864
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and cardiovascular effects of salbutamol in atopic subjects with and without asthma.
Kallenbach J; Joffe BI; Zwi S; Seftel HC
Scand J Respir Dis; 1979 Feb; 60(1):44-8. PubMed ID: 220703
[TBL] [Abstract][Full Text] [Related]
13. Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
Giugliano D; Passariello N; Torella R; Cerciello T; Varricchio M; Sgambato S
Acta Diabetol Lat; 1981; 18(1):27-36. PubMed ID: 7211088
[TBL] [Abstract][Full Text] [Related]
14. Effects of sympathetic activation on plasma renin activity in the developing rat.
Kirby RF; Johnson AK
J Pharmacol Exp Ther; 1990 Apr; 253(1):152-7. PubMed ID: 2184217
[TBL] [Abstract][Full Text] [Related]
15. The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin.
St-Pierre DH; Benso A; Gramaglia E; Prodam F; Lucatello B; Ramella-Gigliardi V; Olivetti I; Tomelini M; Broglio F
J Endocrinol Invest; 2010 Jun; 33(6):363-7. PubMed ID: 20631491
[TBL] [Abstract][Full Text] [Related]
16. Effect of the partial beta-agonist prenalterol on plasma renin activity in patients with left ventricular failure.
Wathen CG; Mackay IG; Glover DR; Roulston JE
Clin Chim Acta; 1987 Jan; 162(1):97-100. PubMed ID: 3542308
[TBL] [Abstract][Full Text] [Related]
17. Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man.
Al-Damluji S; Perry L; Tomlin S; Bouloux P; Grossman A; Rees LH; Besser GM
Neuroendocrinology; 1987 Jan; 45(1):68-76. PubMed ID: 3027604
[TBL] [Abstract][Full Text] [Related]
18. Airway and metabolic resistance to intravenous salbutamol: a study in normal man.
Holgate ST; Stubbs WA; Wood PJ; McCaughey ES; Alberti KG; Tattersfield AE
Clin Sci (Lond); 1980 Sep; 59(3):155-61. PubMed ID: 7000415
[TBL] [Abstract][Full Text] [Related]
19. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
Reverte M; Rivas-Cabañero L
Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
[TBL] [Abstract][Full Text] [Related]
20. The systemic beta-adrenergic pathway to renin secretion: relationships with the renal prostaglandin system.
Henrich WL; Campbell WB
Endocrinology; 1983 Dec; 113(6):2247-54. PubMed ID: 6139275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
